Exploring the Neuroprotective Potential of Functional Mushrooms: A Comprehensive Review
Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and stroke continue to challenge global healthcare with limited therapeutic options. Functional mushrooms, especially Hericium erinaceus (Lion’s Mane), Ganoderma lucidum (Reishi), Cordyceps sinensis, and Inonotus obliquus (Chaga), have shown promising neuroprotective properties. These benefits are linked to their antioxidant, anti-inflammatory, and neurotrophic effects and their support of mitochondrial health and gut-brain axis regulation. Evidence from preclinical studies highlights their ability to reduce oxidative stress, modulate microglial activity, and support synaptic function. Emerging clinical data also suggest improvements in cognition. However, issues like poor bioavailability, lack of standardised formulations, and limited large-scale trials remain barriers. Future research, including nanotechnology-based delivery and synergistic formulations, may unlock their full potential in neurodegenerative therapy and drug development. Major Findings: Functional mushrooms like Lion’s Mane, Reishi, Cordyceps, and Chaga exhibit neuroprotective effects through antioxidant, anti-inflammatory, and neurotrophic actions targeting cellular pathways such as Nrf2/ARE and microglial modulation. Advanced delivery systems and synergistic use with compounds like curcumin and resveratrol enhance their therapeutic potential.